Biopharma News : Biopharma and Pharma news from all around the world :
- Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MedX Health Corp. Appoints Lesley Bourget as Chief Financial Officer
- Cresco Labs Opens Sunnyside Dispensary in Wyomissing, Pennsylvania
- Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
- AHF Praises HRSA for Recent Action to Defend Vital 340B Program
- AmerisourceBergen & Global Pharmaceutical Manufacturers Discuss “Moving Health Forward” at Second Annual ThinkLive Trade Virtual Conference
- Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Glaucoma Innovation Showcase
- Taro to Announce Second Quarter Results on October 28, 2021
- AstraZeneca and Bob Harper Unveil the Survivors Have Heart Second Chance Portraits to Change the Face of Heart Attack Survivorship
- ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
- Global Drug Of Abuse Testing Services Market Report 2021: Drug Testing is Considered a Violation of Privacy Rights in Some Countries – ResearchAndMarkets.com
- Global Centrifugal Evaporator Market Insights (2021 to 2026) – Key Analysis and Forecasts – ResearchAndMarkets.com
- Senior Leaders from Google Confirmed to Speak at BIOMEDevice Silicon Valley ‘Smart Event’
- Worldwide Hair Loss Treatment Products Industry to 2027 – Featuring Kirkland Signature, Cipla and Ales Groupe Among Others – ResearchAndMarkets.com
- Newly Published Data Continue to Support Long-Term Efficacy of TEPEZZA® (teprotumumab-trbw) for Thyroid Eye Disease (TED)
- Median Technologies Reports on Its 2021 Half-Year Results and Its Q3 2021 Business Activity Indicators
- Shionogi Presents the Results of COVID-19 Therapeutic Agent at ISIRV-WHO Virtual Conference
- Biospecimen Contract Research Services Market, 2030 – ResearchAndMarkets.com
- Research Reveals Trivalent PROTACs More Potent in Targeted Protein Degradation
- Global RNA Analysis Market Research Report 2021 – ResearchAndMarkets.com
- Global Polymerase Chain Reaction Consumables Market (2020 to 2027) – by Product Type, Technology, Application, End-user and Geography – ResearchAndMarkets.com
- Prefillable Biological Drug Delivery Systems Market Report 2021 – ResearchAndMarkets.com
- Biognosys to Present Major Scientific and Technological Advances at the ASMS 2021 Mass Spectrometry Conference
- IDC MarketScape Names ZS a Leader in R&D Strategic Consulting and a Major Player in IT Outsourcing (ITO)
- RefleXion Highlights New Cancer Treatment Research at ASTRO 2021
- BIOVECTRA Announces Appointment of Steven M. Klosk and Gordon C. Mccauley to Board
- Outlook on the Pharmaceutical Isolator Global Market to 2028 – by Type, Pressure, Configuration, Application, End-user and Geography – ResearchAndMarkets.com
- Personalis to Announce Third Quarter Financial Results on November 4, 2021
- AngMar Medical Holdings, Inc. Expands Angels Care Home Health Brand With Purchase of New Provider
Biotech – Biopharma News!
- Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF(TM) from the European Medicines Agency
- Successful capital increase with significant oversubscription: Appreciation of management’s performance in aap’s transformation process in COVID-19 times; financing secured at least until end of 2023
- Zur Rose Group: Board of Directors nominates Walter Oberhänsli as Chairman and appoints Walter Hess as new CEO
- Zur Rose Group continues to grow strongly
- MorphoSys AG: First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin A Nephropathy
- Result of the capital increase with subscription rights: capital measure significantly oversubscribed; issue of 1.5 million new shares leads to gross issue proceeds of almost EUR 5 million
- Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers
- Medacta extends the personalized medicine concept to total knee revision surgeries with the unique and innovative MyKnee R patient-specific solution
- Formycon and SCG Cell Therapy Announce Collaboration and License Agreement for Formycon’s COVID-19 Drug FYB207
- Formycon Concludes Collaboration and License Agreement with SCG Cell Therapy for its COVID-19 Drug FYB207 for the Asia Pacific Region
- ABIVAX: ABX464 shows excellent long-term efficacy data in Abivax’s phase 2b maintenance Trial in ulcerative colitis
- Invitation: Straumann Group 2021 third-quarter financial results webcast
- Original-Research: MagForce AG (von GBC AG)
- Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Business and Progress of Varoglutamstat Clinical Development in Alzheimer’s Disease (news with additional features)
- Swiss Takeover Board confirms Absence of an Obligation to make a Public Takeover Offer in connection with planned Enbiotix Merger
- Relief Reports U.S. Collaboration Partner Announces Journal of Infectious Diseases and Treatment Publishes Positive Aviptadil Data in High Comorbidity Critical COVID-19 Patients w/ Respiratory Failure
- Drägerwerk AG & Co. KGaA: In the third quarter, net sales and EBIT were below the strong prior-year level. Overall strong business performance in the first nine months. Outlook confirmed.
- Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF(TM)
- aap’s transformation continues: Marc Langner strengthens Supervisory Board
- MagForce AG: MagForce USA, Inc. has Received FDA’s Conditions for Approval of the Final Protocol of the Pivotal U.S. Study for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System
- Defence Therapeutics Inc.: DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER
- Relief Reports that its U.S. Collaboration Partner has Announced Progress on Worldwide Commercial Scale Development of ZYESAMI(TM) (aviptadil)
- SynBiotic SE plans Canadian cross-listing
- APEIRON Biologics commences clinical COVID-19 trial with inhaled APN01
- Capital Markets Day 2021: Lonza to Capture Market Demand and Ensure Sustainable Value Creation Through Long-Term Growth
- Gerresheimer AG: Gerresheimer on growth course
- Eckert & Ziegler Acquires 53,000 Square Feet Facility for Expansion of Contract Development and Manufacturing Services
- MorphoSys’ Licensing Partner Roche Received Breakthrough Therapy Designation for Gantenerumab in Alzheimer’s Disease
- Vita 34 AG extends the acceptance period under PBKM exchange offer
- Evotec SE files registration statement for proposed offering of American Depositary Shares
- Sio Gene Therapies Announces Reorganization of R&D Group
- Chembio Diagnostics to Report Third Quarter 2021 Financial Results on November 4, 2021
- PDS Biotechnology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Genocea to Host Third Quarter 2021 Corporate Update Conference Call & Webcast
- Treace Announces Grant of Additional U.S. Patent on Instrumented Bunion Correction
- OliX Pharmaceuticals to Conduct One-on-One Meetings at BIO-Europe Digital 2021 Conference
- Cue Biopharma Announces Publication in The Journal of Clinical Investigation Highlighting Immuno-STAT Biologics for the Treatment of Chronic Infectious Diseases
- Guerbet: Revenue at September 30, 2021
- Todos Medical Announces Publication in Journal of Clinical Virology Highlighting Clinical Utility of cPass Semi-Quantitative Neutralizing Antibody Test in SARS-CoV-2 Risk Assessment Post-Vaccination or Recovery from Infection
- CBD Oil King: Trusted British CBD Company Has the Lowdown on CBD and CBG Isolates
- Senti Bio CEO Appointed to The Alliance for Regenerative Medicine 2022 Board of Directors
- Neovasc Reducer™ Featured in Polish Heart Journal
- PAOG Announces CBD “RX” Brand Introducing Second CBD Product
- Philips brings clarity to every moment of cancer care with new patient-centered innovations at ASTRO 2021
- Accumulus Synergy Announce the Appointment of Christopher Jeschke as Chief Technology Officer
- Ultimovacs Receives Dual FDA Fast Track Designation for UV1 in Advanced Malignant Melanoma
- Share Capital Consolidation and Commencement of trading in the New Tiziana Shares on NASDAQ
- Linneo Health announces GMP certification of quality control laboratory by AEMPS
- Ultimovacs Receives Dual FDA Fast Track Designation for UV1 in Advanced Malignant Melanoma
- Special Needs Dentist Fort Worth TX, Adult Disability Dentist Treatments Updated
- argenx to Report Third Quarter 2021 Financial Results and Business Update on October 28, 2021
- MDxHealth Provides Q3-2021 Business Update
- Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering
- 23andMe to Report FY2022 Second Quarter Financial Results on November 10, 2021
- Palette Life Sciences Announces Completion of $30 Million Equity Financing and Expansion of the Board of Directors
- FDA expands approval of Dupixent® (dupilumab) to include children aged 6 to 11 years with moderate-to-severe asthma
- The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical trial with lanifibranor in NASH
- Cigna Adds Iora Primary Care to Medicare Advantage Network in Phoenix Area
- Viemed Healthcare Announces Date and Time for Conference Call
- Checkmate Pharmaceuticals Announces Webcast on Innate Immune Modulators and Vidutolimod (CMP-001)
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News